Showing 9 of 9 recruiting trials for “rare-tumor-of-gallbladder-and-extrahepatic-biliary-tract”
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
RecruitingNCT07337850 ↗
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
👨⚕️ Salah-Eddin SE Al-Batran, Prof. Dr., Frankfurter Institut fuer Klinische Krebsforschung IKF GmbH📍 10 sites📅 Started Aug 2024View details ↗
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RecruitingNCT07007832 ↗
Bile Omics for Diagnosing Indeterminate Biliary Strictures
👨⚕️ Xueying Ding, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2024View details ↗
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
👨⚕️ Jonathan M Hernandez, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05404347 ↗
NGS in Gallbladder Cancer and Response to Treatment
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →